Related Experiment Video
Updated: Dec 28, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
895
Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside
Jinghua Wang1,2, Shushan Yan3, Jinghan Yang1,2
1Clinical Medicine College, Weifang Medical University, Weifang, China.
Frontiers in Immunology
|February 13, 2020
Summary
This review explores how non-coding RNAs (ncRNAs) contribute to rheumatoid arthritis (RA) pathogenesis. Identifying these ncRNAs may lead to new diagnostic biomarkers for RA.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Rheumatoid arthritis (RA) is a systemic autoimmune disease causing joint inflammation and destruction.
- Synovitis and vasculitis are key pathological features of RA.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their roles in immune regulation.
Purpose of the Study:
- To review the role of ncRNAs in rheumatoid arthritis pathogenesis.
- To highlight ncRNAs as potential diagnostic and therapeutic biomarkers for RA.
Main Methods:
- Literature review of studies on ncRNAs and RA.
- Analysis of the regulatory functions of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in RA.
Main Results:
- ncRNAs, including miRNAs, lncRNAs, and circRNAs, are critical regulators in RA.
- Specific ncRNAs have been identified as promising biomarkers for RA diagnosis and treatment.
- Understanding ncRNA regulation offers insights into RA pathophysiology.
Conclusions:
- ncRNAs play a significant role in the development and progression of rheumatoid arthritis.
- Targeting ncRNAs presents a potential strategy for RA diagnosis and therapy.
- Further research into ncRNA biomarkers is crucial for advancing RA management.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
The JAK-STAT Signaling Pathway
11.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.6K
Leaky Scanning
5.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K

